NAVARINI, LUCA
 Distribuzione geografica
Continente #
AS - Asia 5.363
NA - Nord America 1.478
EU - Europa 660
SA - Sud America 291
AF - Africa 46
OC - Oceania 14
Totale 7.852
Nazione #
SG - Singapore 4.028
US - Stati Uniti d'America 1.400
CN - Cina 641
HK - Hong Kong 370
BR - Brasile 222
IT - Italia 167
VN - Vietnam 167
GB - Regno Unito 158
DE - Germania 82
NL - Olanda 67
CA - Canada 42
IN - India 41
FI - Finlandia 36
MX - Messico 30
AR - Argentina 25
AT - Austria 21
ID - Indonesia 21
ES - Italia 20
JP - Giappone 20
ZA - Sudafrica 19
TR - Turchia 18
PL - Polonia 17
EC - Ecuador 16
UA - Ucraina 16
FR - Francia 15
BD - Bangladesh 13
AU - Australia 12
EG - Egitto 11
LT - Lituania 11
CO - Colombia 10
RU - Federazione Russa 10
PE - Perù 8
IR - Iran 7
DK - Danimarca 6
CZ - Repubblica Ceca 5
SE - Svezia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
CL - Cile 4
IL - Israele 4
EE - Estonia 3
IE - Irlanda 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
MY - Malesia 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
TL - Timor Orientale 3
TN - Tunisia 3
BO - Bolivia 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
NC - Nuova Caledonia 2
PH - Filippine 2
PK - Pakistan 2
RS - Serbia 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BJ - Benin 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
YT - Mayotte 1
Totale 7.852
Città #
Singapore 486
Hong Kong 363
Ashburn 309
Dallas 262
Hefei 257
San Jose 190
Boardman 136
Beijing 123
London 120
Shanghai 81
Council Bluffs 77
Ho Chi Minh City 65
Amsterdam 54
Munich 50
Rome 42
Los Angeles 38
Hanoi 35
Santa Clara 25
Turku 23
São Paulo 19
Toronto 18
Ankara 16
San Francisco 16
Bari 15
Brooklyn 15
Mexico City 15
New York 15
Pune 15
Tokyo 15
Warsaw 15
Washington 15
Atlanta 13
Haiphong 13
Helsinki 12
Chennai 11
Hangzhou 10
Johannesburg 10
Boston 9
Jinan 9
Milan 9
Seattle 9
Chicago 8
Jaguariúna 8
Nuremberg 8
Qingdao 8
West Jordan 8
Changsha 7
Guangzhou 7
Leicester 7
Montreal 7
Vienna 7
Charlotte 6
Guayaquil 6
Las Vegas 6
Melbourne 6
Naples 6
Hải Dương 5
Manaus 5
Paris 5
Pisa 5
Rio de Janeiro 5
Biên Hòa 4
Brasília 4
Brno 4
Chaozhou 4
Cotia 4
Da Nang 4
Kongens Lyngby 4
Noicattaro 4
Porto Alegre 4
Secaucus 4
Shijiazhuang 4
State College 4
Stockholm 4
Sydney 4
Thái Bình 4
Xi'an 4
Andradina 3
Bauru 3
Buenos Aires 3
Cairo 3
Can Tho 3
Cape Town 3
Chengdu 3
Denver 3
Dili 3
Dublin 3
Frankfurt am Main 3
Guarulhos 3
Lima 3
Nairobi 3
New Delhi 3
Poplar 3
Quito 3
Redmond 3
Sofia 3
São Luís 3
Tashkent 3
Tel Aviv 3
Tunis 3
Totale 3.293
Nome #
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues. 210
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 206
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 201
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 200
New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report 192
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 190
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 179
Leptin in immuno-rheumatological diseases 178
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 172
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 172
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 157
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 156
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 136
Adult-onset Still's disease with elderly onset: results from a multicentre study 134
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 129
Personal attitudes and denialist views about the COVID-19 pandemic in Italy: a national survey 128
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies 111
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 107
A longitudinal study on caring behaviors of Italian nursing students 106
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 106
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 102
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 100
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 98
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 96
Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy 95
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 95
Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism 94
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 94
Beauty is not perfection: what Leonardo’s Lady with an Ermine can suggest to aesthetic surgery 94
Cannabinoids in Autoimmune and Rheumatic Diseases 92
Leptin in autoimmune mechanisms of systemic rheumatic diseases 90
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 89
Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy 75
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 73
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 70
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 70
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 69
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 64
Polypharmacy is a determinant of hospitalization in Parkinson's disease 62
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 58
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 56
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 53
Role of the specialized proresolving mediator resolvin D1 in systemic lupus erythematosus: preliminary results 53
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 51
Development and implementation of the AIDA International Registry for patients with Behçet's disease 49
The Association of Olfactory Dysfunction, Frailty, and Mortality Is Mediated by Inflammation: Results from the InCHIANTI Study 46
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 45
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 45
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 44
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 44
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 43
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 43
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 43
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 42
Euthymic despite pain: the role of cognitive reappraisal and experiential avoidance in autoimmune inflammatory rheumatic diseases—a cross-sectional study 39
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 39
Pattern of sleep dysfunction in systemic lupus erythematosus: a cluster analysis 39
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 39
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study 38
Erythema Multiforme Induced by Secukinumab: Clinical, Dermoscopic, and Histological Features 38
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 38
Patients with psoriatic arthritis and comorbid metabolic syndrome show a difficult-to-treat phenotype: another mosaic tile in the definition of a still undefined subset of patients 38
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". 38
LOW-DOSE ASPIRIN MAY HAVE A ROLE AS PRIMARY PROPHYLAXIS OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: EVIDENCE FROM AN ITALIAN MULTICENTRIC RETROSPECTIVE STUDY 38
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 38
JAK inhibitors in immune-mediated rheumatic diseases: From a molecular perspective to clinical studies 38
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in seronegative rheumatoid arthritis patients 38
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 37
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 37
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 37
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 37
The relation between, metabolic syndrome and quality of life in patients with Systemic Lupus Erythematosus 37
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 37
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 37
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 36
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 36
Female sexual dysfunction in systemic sclerosis: The role of endothelial growth factor and endostatin 35
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease Registry 35
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 35
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 35
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 35
Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future 34
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 34
Matters of the heart: The case of TNF-alpha targeting drugs 34
Polyunsaturated fatty acids: any role in rheumatoid arthritis? 33
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis 33
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 32
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study 32
Utility of ultrasound in the diagnosis of chronic worsened gout 31
Physical activity and sedentary behavior in patients with Systemic Lupus Erythematosus 31
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 31
Inflammation as a mediator of the association between osteoporosis and hearing loss in older subjects: a population-based study 31
Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art 31
Phase angle could be a marker of microvascular damage in systemic sclerosis 31
Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints 30
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 30
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 30
Endothelial-to-mesenchymal transition in systemic sclerosis 30
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 30
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 29
Totale 7.108
Categoria #
all - tutte 49.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 1 2 0 0 0 2 4 21 6 2 81
2022/2023165 1 0 5 4 60 0 6 5 6 7 63 8
2023/2024422 16 53 18 50 45 164 8 18 7 12 21 10
2024/20254.807 49 58 141 90 92 131 73 21 321 328 1.545 1.958
2025/20262.463 490 229 479 528 232 279 226 0 0 0 0 0
Totale 7.976